JPRN-UMIN000005619已完成2 期
A phase II study of Docetaxel with Bevacizumab in chemotherapy naïve elderly patients with advanced non-squamous non-small-cell lung cancer - A phase II study of Docetaxel with Bevacizumab elderly patients with NSCLC
Osaka Lung Cancer Study Group0 个研究点目标入组 35 人开始时间: 2011年5月19日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 35
研究概览
简要总结
not yet
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 70years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) squamous cell carcinoma 2) Interstitial pneumonia or pulmonary fibrosis detectable on Chest X-ray 3) Pleural effusion, pericardial effusion and ascites to need treatment 4) Severe renal function disorder 5) SVC syndrome 6) Brain metastases with neurological symptoms 7) Active double cancer 8) Uncontrollable diabetes mellitus and hypertenson 9) Liver cirrhosis by image findings or laboratory examinations 10) History of severe heart disease (myocardial infarction within 6 months, unstable angina, post-PTCA or CAGB, signs of congestive heart failue, arrythmia with past history of heart failure, etc.) 11) Pregnancy, breast feeding and suspected pregnancy 12) History of grave drug allergic reaction 13) Acute inflammatory disease 14) An agreement is not obtained for support therapy such as transfusion etc 15) Having the bleeding tendency which is clinically apparent 16) Patients whose participation in the trial is judged to be inappropriate by the attendeing doctor
研究者
相似试验
已完成
2 期
A phase II study of Docetaxel with Bevacizumab for EGFR mutation negative previously treated non-squamous non-small cell lung canceron-Squamous Non-Small Cell Lung CancerJPRN-UMIN000006532ihon University School of Medicine30
已完成
不适用
A phase II study of Docetaxel with Bevacizumab for previously treated non-squamous non-small cell lung cancer.non-squamous non-small cell lung cancer.JPRN-UMIN000008687First Department of Internal Medicine,25
已完成
1 期
Phase I/II study of Docetaxel with Bevacizumab for refractory and geriatric non-squamous non-small cell lung canceron-Squamous Non-Small Cell Lung CancerJPRN-UMIN000006152Chiba Tokushukai Hospital20
招募中
2 期
A Phase 2 study of Docetaxel and Bevacizumab as the second line treatment for patients with non-squamous non-small cell lung cancer previously treated with platinum-based chemotherapy.non-squamous non-small cell lung cancerJPRN-UMIN000006641Kinki University Faculty of Medicine, Nara Hospital41
进行中（未招募）
不适用
A phase II study of Bevacizumab with Docetaxel and Capecitabine in the neoadjuvant setting for breast cancer patientsneoadjuvant treatment of patients with primary breast cancer and no distant metastasesEUCTR2005-005883-10-ATRoche Austria GmbH10